Payment overview · 2025
General Payments
$36.86
2 reported records · 2 companies
Healthcare provider profile · identity verified
Dee Alan Roach, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · COLORADO CITY, TX · NPI 1275542854
Verified facts
What the public records show
CMS Open Payments records show Dee Alan Roach, M.D. received $36.86 in general payments during 2025 across 2 reported records.
ABBVIE INC. accounted for 55.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 56 claims for Synthroid by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 292 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $20.50 | 55.6% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $16.36 | 44.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $36.86 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $20.50 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $16.36 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 292 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
56 | 17 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
292 | 44 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 854 | 161 |
| Levothyroxine Sodium | Levothyroxine Sodium | 826 | 129 |
| Amlodipine Besylate | Amlodipine Besylate | 815 | 141 |
| Gabapentin | Gabapentin | 783 | 122 |
| Pantoprazole Sodium | Pantoprazole Sodium | 735 | 128 |
| Losartan Potassium | Losartan Potassium | 560 | 116 |
| Metoprolol Succinate | Metoprolol Succinate | 462 | 93 |
| Trazodone Hcl | Trazodone Hcl | 446 | 62 |
| Lisinopril | Lisinopril | 424 | 81 |
| Furosemide | Furosemide | 402 | 74 |
| Tamsulosin Hcl | Tamsulosin Hcl | 365 | 58 |
| Clopidogrel | Clopidogrel Bisulfate | 337 | 52 |
| Tramadol Hcl | Tramadol Hcl | 335 | 74 |
| Potassium Chloride | Potassium Chloride | 328 | 52 |
| Metformin Hcl | Metformin Hcl | 318 | 74 |
| Duloxetine Hcl | Duloxetine Hcl | 301 | 45 |
| Ozempic | Semaglutide | 292 | 44 |
| Meloxicam | Meloxicam | 272 | 39 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 241 | 36 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 241 | 49 |
| Paroxetine Hcl | Paroxetine Hcl | 235 | 42 |
| Metoprolol Tartrate | Metoprolol Tartrate | 198 | 31 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 190 | 44 |
| Allopurinol | Allopurinol | 186 | 27 |
| Omeprazole | Omeprazole | 181 | 32 |
| Donepezil Hcl | Donepezil Hcl | 179 | 13 |
| Simvastatin | Simvastatin | 179 | 30 |
| Clonazepam | Clonazepam | 177 | 18 |
| Tizanidine Hcl | Tizanidine Hcl | 173 | 32 |
| Sertraline Hcl | Sertraline Hcl | 169 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 161 | 22 |
| Carvedilol | Carvedilol | 160 | 38 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 158 | 35 |
| Celecoxib | Celecoxib | 158 | 26 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 155 | 30 |
| Pregabalin | Pregabalin | 154 | 36 |
| Buspirone Hcl | Buspirone Hcl | 149 | 30 |
| Jardiance | Empagliflozin | 148 | 26 |
| Fluoxetine Hcl | Fluoxetine Hcl | 147 | 24 |
| Levetiracetam | Levetiracetam | 140 | suppressed |
| Famotidine | Famotidine | 138 | 19 |
| Glipizide | Glipizide | 138 | 27 |
| Alprazolam | Alprazolam | 136 | 25 |
| Zolpidem Tartrate | Zolpidem Tartrate | 134 | 19 |
| Hydrochlorothiazide | Hydrochlorothiazide | 132 | 27 |
| Eliquis | Apixaban | 130 | 20 |
| Farxiga | Dapagliflozin Propanediol | 127 | 27 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 123 | 27 |
| Escitalopram Oxalate | Escitalopram Oxalate | 116 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 115 | 14 |
| Prednisone | Prednisone | 112 | 55 |
| Memantine Hcl | Memantine Hcl | 107 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 104 | 18 |
| Warfarin Sodium | Warfarin Sodium | 98 | 13 |
| Mirtazapine | Mirtazapine | 93 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 92 | suppressed |
| Sucralfate | Sucralfate | 91 | 19 |
| Fluticasone Propionate | Fluticasone Propionate | 90 | 34 |
| Ondansetron Odt | Ondansetron | 90 | 31 |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 87 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 87 | 14 |
| Montelukast Sodium | Montelukast Sodium | 86 | 20 |
| Clonidine Hcl | Clonidine Hcl | 83 | 11 |
| Pravastatin Sodium | Pravastatin Sodium | 83 | 18 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 81 | 33 |
| Azithromycin | Azithromycin | 78 | 69 |
| Ezetimibe | Ezetimibe | 75 | 17 |
| Meclizine Hcl | Meclizine Hcl | 75 | 13 |
| Amiodarone Hcl | Amiodarone Hcl | 74 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 73 | suppressed |
| Estradiol | Estradiol | 72 | 20 |
| Glipizide Er | Glipizide | 71 | 17 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 67 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 65 | 14 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 63 | 13 |
| Januvia | Sitagliptin Phosphate | 61 | suppressed |
| Diazepam | Diazepam | 59 | suppressed |
| Finasteride | Finasteride | 59 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 57 | 16 |
| Atenolol | Atenolol | 56 | 13 |
| Synthroid | Levothyroxine Sodium | 56 | 17 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 55 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 55 | 11 |
| Cephalexin | Cephalexin | 54 | 23 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 54 | suppressed |
| Lorazepam | Lorazepam | 53 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 51 | 13 |
| Lactulose | Lactulose | 51 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 50 | 14 |
| Naproxen | Naproxen | 49 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 48 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 48 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 47 | suppressed |
| Nifedipine Er | Nifedipine | 46 | suppressed |
| Baclofen | Baclofen | 45 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 44 | 29 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 43 | 28 |
| Ibuprofen | Ibuprofen | 43 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 42 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 42 | 31 |
| Benazepril Hcl | Benazepril Hcl | 41 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 41 | 32 |
| Oxycodone Hcl | Oxycodone Hcl | 41 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 41 | 11 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 40 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 40 | suppressed |
| Lansoprazole | Lansoprazole | 40 | suppressed |
| Methocarbamol | Methocarbamol | 40 | suppressed |
| Temazepam | Temazepam | 39 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 38 | suppressed |
| Aripiprazole | Aripiprazole | 37 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 37 | suppressed |
| Spironolactone | Spironolactone | 37 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 36 | 29 |
| Risperidone | Risperidone | 36 | suppressed |
| Telmisartan | Telmisartan | 36 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 33 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 32 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 32 | suppressed |
| Acyclovir | Acyclovir | 31 | suppressed |
| Phenytoin | Phenytoin | 31 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 31 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 30 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 30 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 30 | suppressed |
| Topiramate | Topiramate | 30 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 28 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 28 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 28 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 28 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 28 | suppressed |
| Levofloxacin | Levofloxacin | 28 | 24 |
| Carbamazepine | Carbamazepine | 27 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 27 | suppressed |
| Xarelto | Rivaroxaban | 27 | suppressed |
| Cefadroxil | Cefadroxil | 26 | suppressed |
| Gemtesa | Vibegron | 26 | suppressed |
| Olanzapine | Olanzapine | 26 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 26 | suppressed |
| Mupirocin | Mupirocin Calcium | 25 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 25 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 25 | suppressed |
| Zonisamide | Zonisamide | 25 | suppressed |
| Bumetanide | Bumetanide | 24 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 23 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 23 | 15 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 23 | 21 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 22 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 22 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 22 | suppressed |
| Movantik | Naloxegol Oxalate | 22 | suppressed |
| Fluconazole | Fluconazole | 21 | 15 |
| Hydroxyurea | Hydroxyurea | 21 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 21 | suppressed |
| Torsemide | Torsemide | 21 | suppressed |
| Trulicity | Dulaglutide | 21 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 20 | suppressed |
| Metolazone | Metolazone | 19 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 19 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 19 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 18 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 18 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 18 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 17 | suppressed |
| Carbamazepine Er | Carbamazepine | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 16 | suppressed |
| Lubiprostone | Lubiprostone | 16 | suppressed |
| Nystatin | Nystatin | 16 | 12 |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 15 | suppressed |
| Glimepiride | Glimepiride | 15 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 15 | 12 |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 15 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 14 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 14 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 14 | suppressed |
| Novolog Flexpen | Insulin Aspart | 14 | suppressed |
| Enbrel Sureclick | Etanercept | 13 | suppressed |
| Humalog | Insulin Lispro | 13 | suppressed |
| Ketoconazole | Ketoconazole | 13 | suppressed |
| Levemir | Insulin Detemir | 13 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 13 | suppressed |
| Telmisartan-Amlodipine | Telmisartan/Amlodipine | 13 | suppressed |
| Valsartan | Valsartan | 13 | suppressed |
| Chlordiazepoxide-Amitriptyline | Amitriptyline/Chlordiazepoxide | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | 11 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Mesalamine Er | Mesalamine | 12 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 12 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 12 | suppressed |
| Amoxicillin | Amoxicillin | 11 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 11 | suppressed |
| Enulose | Lactulose | 11 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 11 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 11 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $36.86 · 2 records | ABBVIE INC. | Ozempic, VRAYLAR | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error